Healthcare Law News: News on Healthcare Law continually updated from thousands of sources monitored by the B Media Network.
Pages
▼
Thursday, February 27, 2014
Can Pharmacyclics, Inc.'s Imbruvica Stay Ahead of Gilead Sciences, Inc.'s Idelalisib?
Analysts are predicting some impressive sales, and the market has noticed. The company's stock price has risen over 40% this year, while the broad market remained somewhat flat.
No comments:
Post a Comment